News

Patient in Focus underlines the importance of clinical trial access across borders

Patient in Focus underlines the importance of clinical trial access across borders
Partnership and Growth
Member News

Patient in Focus (www.patientinfocus.org) is part of a multi-stakeholder initiative on cross-border access to clinical trials (EU-X-CT). The project aims to analyse the current situation of cross-border access to clinical trials in the EU with an overview of stakeholders’ real-life experiences and to identify needs, challenges and potential to facilitate cross-border access. Today there is over 50 organizations from industry, academia, and patient organizations, all of which have agreed to participate in this project.

To support patient communities, investigators, and trial sponsors in enabling cross-border access to clinical trials when appropriate, EFGCP and EFPIA have set up a multi-stakeholder consortium of patient organisations, academia, research networks and industry with the aim to develop recommendations to enable cross-border access to clinical trials for patients across the EU.

With no current European Framework to define the conditions for cross border clinical trials, the project will map out the current state of each Member State, detailing the logistical and financial support required as well as issues like accessing ongoing treatment for those patients involved. The project will be vital in bringing groundbreaking trials to patients in countries who previously had no access and could revolutionise treatment options for those with rare diseases.

Read the full press release here

Discover more about Patient in Focus

Patient in Focus (www.patientinfocus.org) is an international, disease neutral, nonprofit patient organization based in Europe. Built by patients for patients. Patient in Focus provides the opportunity to make a difference for yourself and others by being a voice with healthcare professionals, researchers, industry, academics etc. We do this through patient engagement, counseling, and a strong patient community, where we can create life-changing purpose and quality of life despite chronic illness, pain, and disabled.

NEWS​

Related News

Tackling obesity

8 Jul 2024
Apply for funding to develop effective strategies to tackle overweight and obesity. ‘Tackling obesity’ is open to applications submitted to the Popula...

Cancer research transatlantic development and skills enhancement award 2024

4 Jul 2024
Following the UK-US Cancer Summit, MRC and NIHR, in partnership with NCI, are launching a second competition for the cancer research transatlantic dev...

24/52 Liver Disease (EME Programme)

4 Jul 2024
The Efficacy and Mechanism Evaluation (EME) Programme is accepting Stage 1 applications to this funding opportunity.

24/50 Efficacy studies seeking to improve the health and wellbeing of women

4 Jul 2024
The Efficacy and Mechanism Evaluation (EME) Programme is accepting applications to their commissioned workstream.

Small Research Grants

4 Jul 2024
Throughout the year, we consider applications and allocate small amounts of funding for innovative research into neuroblastoma.

24/13 Digital Technology enabled interventions in Social Care commissioning brief

4 Jul 2024
The aim of the Health Technology Assessment (HTA) Programme is to ensure that high quality research information on the clinical effectiveness, cost-ef...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *